PolarityTE (PTE.Q) has provided an update regarding correspondence from the U.S. Food and Drug Administration (FDA) related to the Company’s Investigational New Drug Application (IND) for SkinTE®, which was…
Latest News
Beacn Wizardry and Magic (BECN.V) financials show 79% ramp up in sales
Tisdale Clean Energy Corp. Launches $1.2 Million Private Placement for Working Capital
Top 5 stock gainers and losers: SHL.V, MMY.V, IVX.V
The world’s richest people are investing in sport – why, and how can you join them?
Marvel Discovery (MARV.V) Secures Funding and Expands Exploration Despite Market Headwinds
Searchlight Resources updates quarterly activity